Literature DB >> 23100270

The vasohibin family: a novel family for angiogenesis regulation.

Yasufumi Sato1.   

Abstract

Angiogenesis, a formation of neovessels, is regulated by the local balance between angiogenesis stimulators and inhibitors. A number of such endogenous regulators of angiogenesis have been found in the body. Recently, vasohibin-1 (VASH1) was isolated as a negative feedback regulator of angiogenesis produced by endothelial cells (ECs) and subsequently vasohibin-2 (VASH2) as a homologue of VASH1. It was then explored that VASH1 is expressed in ECs to terminate angiogenesis, whereas VASH2 is expressed in cells other than ECs to promote angiogenesis in the mouse model of angiogenesis. This review will focus on the vasohibin family members, which are novel regulators of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100270      PMCID: PMC3528003          DOI: 10.1093/jb/mvs128

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  44 in total

1.  Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

Authors:  H Sato; T Abe; R Wakusawa; N Asai; H Kunikata; H Ohta; H Sonoda; Y Sato; K Nishida
Journal:  Diabetologia       Date:  2008-12-05       Impact factor: 10.122

2.  Recombinant adenovirus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth.

Authors:  Dajiang Li; Kun Zhou; Shuguang Wang; Zhong Shi; Zhao Yang
Journal:  Cancer Sci       Date:  2009-10-06       Impact factor: 6.716

3.  Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population.

Authors:  Hisamichi Naito; Hiroyasu Kidoya; Yasufumi Sato; Nobuyuki Takakura
Journal:  J Biochem       Date:  2009-01-29       Impact factor: 3.387

4.  Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.

Authors:  Tomoko Hosaka; Hiroshi Kimura; Takahiro Heishi; Yasuhiro Suzuki; Hiroki Miyashita; Hideki Ohta; Hikaru Sonoda; Takuya Moriya; Satoshi Suzuki; Takashi Kondo; Yasufumi Sato
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

5.  Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.

Authors:  Ryosuke Wakusawa; Toshiaki Abe; Hajime Sato; Madoka Yoshida; Hiroshi Kunikata; Yasufumi Sato; Kohji Nishida
Journal:  Am J Ophthalmol       Date:  2008-05-16       Impact factor: 5.258

6.  Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.

Authors:  Hiroshi Kimura; Hiroki Miyashita; Yasuhiro Suzuki; Miho Kobayashi; Kazuhide Watanabe; Hikaru Sonoda; Hideki Ohta; Takashi Fujiwara; Tooru Shimosegawa; Yasufumi Sato
Journal:  Blood       Date:  2009-02-09       Impact factor: 22.113

7.  Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.

Authors:  Kentaro Tamaki; Takuya Moriya; Yasufumi Sato; Takanori Ishida; Yohei Maruo; Kousuke Yoshinaga; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Sci       Date:  2008-11-24       Impact factor: 6.716

Review 8.  Modes of resistance to anti-angiogenic therapy.

Authors:  Gabriele Bergers; Douglas Hanahan
Journal:  Nat Rev Cancer       Date:  2008-08       Impact factor: 60.716

9.  Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts.

Authors:  Kohei Miyake; Keiichiro Nishida; Yasutaka Kadota; Hiroko Yamasaki; Tatsuyo Nasu; Daisuke Saitou; Katsuyuki Tanabe; Hikaru Sonoda; Yasufumi Sato; Yohei Maeshima; Hirofumi Makino
Journal:  Acta Med Okayama       Date:  2009-12       Impact factor: 0.892

10.  Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

Authors:  Tatsuyo Nasu; Yohei Maeshima; Masaru Kinomura; Kumiko Hirokoshi-Kawahara; Katsuyuki Tanabe; Hitoshi Sugiyama; Hikaru Sonoda; Yasufumi Sato; Hirofumi Makino
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more
  38 in total

1.  Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release.

Authors:  Tetsuya Kadonosono; Wanaporn Yimchuen; Takuya Tsubaki; Tadashi Shiozawa; Yasuhiro Suzuki; Takahiro Kuchimaru; Yasufumi Sato; Shinae Kizaka-Kondoh
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

Review 2.  Angiocrine signaling in the hepatic sinusoids in health and disease.

Authors:  Enis Kostallari; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

3.  Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.

Authors:  Shuji Mikami; Mototsugu Oya; Takeo Kosaka; Ryuichi Mizuno; Yasumasa Miyazaki; Yasufumi Sato; Yasunori Okada
Journal:  Lab Invest       Date:  2017-03-13       Impact factor: 5.662

4.  Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation in early hypoxia.

Authors:  Fransky Hantelys; Anne-Claire Godet; Florian David; Florence Tatin; Edith Renaud-Gabardos; Françoise Pujol; Leila H Diallo; Isabelle Ader; Laetitia Ligat; Anthony K Henras; Yasufumi Sato; Angelo Parini; Eric Lacazette; Barbara Garmy-Susini; Anne-Catherine Prats
Journal:  Elife       Date:  2019-12-09       Impact factor: 8.140

5.  Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.

Authors:  K N Slaughter Wade; M F Brady; T Thai; Y Wang; B Zheng; R Salani; K S Tewari; H J Gray; J N Bakkum-Gamez; R A Burger; K N Moore; M A Bookman
Journal:  Gynecol Oncol       Date:  2019-08-10       Impact factor: 5.482

Review 6.  Endocrine and local control of the primate corpus luteum.

Authors:  Richard L Stouffer; Cecily V Bishop; Randy L Bogan; Fuhua Xu; Jon D Hennebold
Journal:  Reprod Biol       Date:  2013-09-14       Impact factor: 2.376

7.  Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.

Authors:  Tao Zhang; Ting-Ting Yu; Dong-Ming Zhang; Xiao-Ming Hou; Xiao-Jun Liu; Da Zhao; Li Shan
Journal:  Med Oncol       Date:  2014-04-20       Impact factor: 3.064

8.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09

9.  Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.

Authors:  Bin Wang; Liang Yang; Qian Zhao; Liping Zhu
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

10.  Closing the tubulin detyrosination cycle.

Authors:  Anna Akhmanova; Helder Maiato
Journal:  Science       Date:  2017-12-15       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.